Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALMEFENE vs NALTREXONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALMEFENE vs NALTREXONE: Safety Overview

Metric NALMEFENE NALTREXONE
Total FAERS Reports 197 25,624
Deaths Reported 77 1,106
Death Rate 39.1% 4.3%
Hospitalizations 118 2,843
Average Patient Age 44.2 yrs 41.3 yrs
% Female Patients 39.3% 43.1%
FDA Approval Date Apr 17, 1995 Apr 13, 2006
Manufacturer Purdue Pharma L.P. Bryant Ranch Prepack
Route INTRAMUSCULAR ORAL
Marketing Status Discontinued Discontinued